Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
K Hamaguchi, H R Gaskins, E H Leite. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes. vol 40. issue 7. 1991-08-02. PMID:1647994. |
immunocytochemical staining of passage 18 cells showed most contained insulin, with less than 5% containing glucagon, and none containing pancreatic polypeptide or somatostatin. |
1991-08-02 |
2023-08-11 |
mouse |
K Hamaguchi, H R Gaskins, E H Leite. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes. vol 40. issue 7. 1991-08-02. PMID:1647994. |
northern-blot analysis confirmed high levels of insulin mrna but only trace glucagon mrna and undetectable somatostatin mrna. |
1991-08-02 |
2023-08-11 |
mouse |
P L Brubaker, T Kazumi, T Hirano, M Vranic, G Steine. Failure of chronic hyperinsulinemia to suppress pancreatic glucagon in vivo in the rat. Canadian journal of physiology and pharmacology. vol 69. issue 3. 1991-08-02. PMID:1676340. |
somatostatin fully suppressed insulin, but although plasma glucagon levels were decreased by somatostatin infusion relative to saline-infused animals, there was still no suppression below basal levels. |
1991-08-02 |
2023-08-11 |
rat |
S Madaus, V Schusdziarra, W Dummer, M Classe. The effect of glucose and insulin on vagally induced gastrin, bombesin-like immunoreactivity and somatostatin secretion from the perfused rat stomach. Neuropeptides. vol 18. issue 4. 1991-07-19. PMID:1675778. |
the effect of glucose and insulin on vagally induced gastrin, bombesin-like immunoreactivity and somatostatin secretion from the perfused rat stomach. |
1991-07-19 |
2023-08-11 |
rat |
S Madaus, V Schusdziarra, W Dummer, M Classe. The effect of glucose and insulin on vagally induced gastrin, bombesin-like immunoreactivity and somatostatin secretion from the perfused rat stomach. Neuropeptides. vol 18. issue 4. 1991-07-19. PMID:1675778. |
previous studies in the isolated perfused rat stomach have shown that elevated glucose and insulin concentrations modulate bli and somatostatin release during arterially administered peptidergic stimuli. |
1991-07-19 |
2023-08-11 |
rat |
S Madaus, V Schusdziarra, W Dummer, M Classe. The effect of glucose and insulin on vagally induced gastrin, bombesin-like immunoreactivity and somatostatin secretion from the perfused rat stomach. Neuropeptides. vol 18. issue 4. 1991-07-19. PMID:1675778. |
in the present study the effect of elevated levels of glucose or insulin was examined on vagally induced changes of gastrin, somatostatin and bli secretion. |
1991-07-19 |
2023-08-11 |
rat |
S Madaus, V Schusdziarra, W Dummer, M Classe. The effect of glucose and insulin on vagally induced gastrin, bombesin-like immunoreactivity and somatostatin secretion from the perfused rat stomach. Neuropeptides. vol 18. issue 4. 1991-07-19. PMID:1675778. |
vagally induced inhibition of somatostatin was attenuated by both concentrations of glucose at either luminal ph while insulin had no effect. |
1991-07-19 |
2023-08-11 |
rat |
H O Andersen, P E Jørgensen, L Bardram, L Hilste. Screening for multiple endocrine neoplasia type 1 in patients with recognized pituitary adenoma. Clinical endocrinology. vol 33. issue 6. 1991-07-18. PMID:1982864. |
the screening consisted of: (1) a family history, (2) a uniform medical history of the patient using a standard questionnaire, and (3) hormonal evaluation including measurements of the serum levels of insulin, gastrin, glucagon, somatostatin, vasoactive intestinal polypeptide and pancreatic polypeptide. |
1991-07-18 |
2023-08-11 |
Not clear |
G H Starich, M Zafirova, R Jablenska, P Petkov, C K Lardinoi. A morphological and immunohistochemical investigation of endocrine pancreata from obese ob+/ob+ mice. Acta histochemica. vol 90. issue 1. 1991-07-15. PMID:1675542. |
additionally, the distribution of gastric inhibitory polypeptide, somatostatin, glucagon, and insulin immunoreactive cells was also quantitated. |
1991-07-15 |
2023-08-11 |
mouse |
S B Reiser, V Schusdziarra, E Bollschweiler, A H Hölscher, J R Siewer. Effect of enteric pacing on intestinal motility and hormone secretion in dogs with short bowel. Gastroenterology. vol 101. issue 1. 1991-07-12. PMID:1675185. |
small intestinal motility and plasma levels of insulin, glucagon, gastrin, somatostatin, and glucose were examined during pacing of the residual jejunum or the isolated loop, respectively, compared with control experiments in the same dogs without pacing. |
1991-07-12 |
2023-08-11 |
Not clear |
S B Reiser, V Schusdziarra, E Bollschweiler, A H Hölscher, J R Siewer. Effect of enteric pacing on intestinal motility and hormone secretion in dogs with short bowel. Gastroenterology. vol 101. issue 1. 1991-07-12. PMID:1675185. |
during pacing of the loop a significant (p less than 0.05-0.01) decrease in the postprandial small intestinal motility index was observed combined with a significant (p less than 0.05) increase in plasma insulin levels, whereas the postprandial increase in glucagon, somatostatin, gastrin, and glucose levels was not different from that in controls. |
1991-07-12 |
2023-08-11 |
Not clear |
M Busch-Sørensen, J J Holst, J Lyngsø. Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man. Journal of endocrinological investigation. vol 14. issue 1. 1991-07-12. PMID:1675225. |
glucose turnover, plasma glucose, ffa, insulin, c-peptide, glucagon, and somatostatin concentrations were determined in the fasting state after a bolus injection of placebo or growth hormone in quantities producing increases in plasma growth hormone levels within the normal physiological range. |
1991-07-12 |
2023-08-11 |
human |
M Busch-Sørensen, J J Holst, J Lyngsø. Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man. Journal of endocrinological investigation. vol 14. issue 1. 1991-07-12. PMID:1675225. |
we found that growth hormone administration resulted in negligible changes in plasma glucose, no significant changes in appearance or disappearance rates of glucose, a moderate increase in ffa and a moderate fall in plasma insulin, c-peptide and glucagon concentrations, while plasma somatostatin levels were unchanged. |
1991-07-12 |
2023-08-11 |
human |
K Arihiro, K Ina. Malignant islet cell tumor of the pancreas with multiple hormone production and expression of CEA and CA19-9. Report of an autopsy case. Acta pathologica japonica. vol 41. issue 2. 1991-07-11. PMID:1675032. |
from the results of histological and immunohistochemical studies, this was diagnosed as a malignant islet cell tumor producing multiple hormones such as insulin, glucagon, somatostatin and pancreatic polypeptide, as well as expressing the tumor-related antigens cea and ca19-9. |
1991-07-11 |
2023-08-11 |
Not clear |
G Boden, F Jadal. Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes. vol 40. issue 6. 1991-07-10. PMID:2040385. |
in study 2, lh or saline was infused as in study 1, but the compensatory insulin release was prevented by intravenous infusion of somatostatin and replacement of basal insulin and glucagon concentrations. |
1991-07-10 |
2023-08-11 |
human |
Z Y Gao, G Drews, J C Henqui. Mechanisms of the stimulation of insulin release by oxytocin in normal mouse islets. The Biochemical journal. vol 276 ( Pt 1). 1991-07-03. PMID:1674863. |
oxytocin (ot) produced a dose-dependent increase in somatostatin, glucagon and insulin release by isolated mouse islets. |
1991-07-03 |
2023-08-11 |
mouse |
E Schiaffino, C Schmid, G Mortar. [Anatomopathologic pictures of chronic pancreatitis]. Pathologica. vol 82. issue 1082. 1991-07-02. PMID:2094839. |
immunoperoxidase staining (pap method) for insulin, glucagon, somatostatin, pancreatic polipeptide (pp), vasoactive intestinal polipeptide (vip) and gastrin, was used to investigate endocrine pancreas. |
1991-07-02 |
2023-08-11 |
Not clear |
E Schiaffino, C Schmid, G Mortar. [Anatomopathologic pictures of chronic pancreatitis]. Pathologica. vol 82. issue 1082. 1991-07-02. PMID:2094839. |
nesidioblastosis was a prominent feature in all cases but one, with a positivity for insulin in 11 cases, for glucagon in 13, for somatostatin in 6 and for pp in 17. |
1991-07-02 |
2023-08-11 |
Not clear |
J C Marker, I B Hirsch, L J Smith, C A Parvin, J O Holloszy, P E Crye. Catecholamines in prevention of hypoglycemia during exercise in humans. The American journal of physiology. vol 260. issue 5 Pt 1. 1991-06-24. PMID:1674642. |
to assess the role of catecholamines in the prevention of hypoglycemia during moderate exercise (approximately 60% peak o2 consumption for 60 min), normal humans were studied with combined alpha- and beta-adrenergic blockade and with adrenergic blockade while changes in insulin and glucagon were prevented with the islet clamp technique (somatostatin infusion with insulin and glucagon infused at fixed rates). |
1991-06-24 |
2023-08-11 |
Not clear |
I B Hirsch, J C Marker, L J Smith, R J Spina, C A Parvin, J O Holloszy, P E Crye. Insulin and glucagon in prevention of hypoglycemia during exercise in humans. The American journal of physiology. vol 260. issue 5 Pt 1. 1991-06-24. PMID:2035626. |
to assess the roles of decrements in insulin and increments in glucagon in the prevention of hypoglycemia during moderate exercise (approximately 60% peak o2 consumption for 60 min), normal young men were studied during somatostatin infusions with insulin and glucagon infused to 1) hold insulin and glucagon levels constant, 2) decrease insulin, 3) increase glucagon, and 4) decrease insulin and increase glucagon during exercise. |
1991-06-24 |
2023-08-11 |
Not clear |